Health Alert:

See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.

Ischemic mitral regurgitation (IMR) affects more than 2 million Americans, and can increase a patient’s risk for adverse cardiovascular events and even death. While there is no definitive treatment for IMR, patients may be treated with mitral valve repair or valve replacement. In a study presented today at the American Heart Association Scientific Sessions 2015 and published in this week's issue of the New England Journal of Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania, in partnership with other institutions in the Cardiothoracic Surgical Trials Network (CTSN), found that recipients of a mitral valve replacement for IMR experienced a lower rate of heart failure and fewer cardiovascular-related hospital readmissions in the two years following surgery.

Share This Page: